AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0

Glimsentro-M1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Sentro Pharma & Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimsentro-M1 Tablet SR

Diabetol Duo SR tablets are a dual-action antidiabetic medication, a combination therapy for adult-onset type 2 diabetes. This medication helps manage blood glucose levels. Diabetol Duo SR should be taken with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of complications like nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, this medication is one component of a comprehensive diabetes management plan, encompassing dietary modifications, regular physical activity, and weight management as advised by your doctor. Lifestyle choices significantly influence diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to identify symptoms like sweating, dizziness, headache, and tremors, and have a readily available fast-acting glucose source (e.g., sugary foods, fruit juice) to counteract this. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.

Uses of Glimsentro-M1 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimsentro-M1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glimsentro-M1 Tablet SR. Ingest the tablet whole; do not crush, chew, or break it before swallowing. Administer this medication with a meal.

Common Side effects of Glimsentro-M1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimsentro-M1 Tablet SR:

Follow your physician's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimsentro-M1 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

How Glimsentro-M1 Tablet SR works:

Glimsentro-M1 SR tablets contain a dual-action antidiabetic formulation: glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood sugar levels. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glimsentro-M1 Tablet SR is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimsentro-M1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Using Glimsentro-M1 SR tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when prescribing Glimsentro-M1 Tablet SR to individuals with kidney impairment; dosage modification may be necessary. Consult a physician. Glimsentro-M1 Tablet SR is contraindicated in patients exhibiting severe kidney dysfunction. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimsentro-M1 Tablet SR to individuals with hepatic impairment. Dosage modification of Glimsentro-M1 Tablet SR may be necessary. Physician consultation is advised. A reduced initial dose of Glimsentro-M1 Tablet SR is typically appropriate for patients exhibiting mild to moderate liver dysfunction; however, its administration is contraindicated in cases of severe liver disease.

What if you forget to take Glimsentro-M1 Tablet SR :

Should you forget a Glimsentro-M1 Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.

Facts to Know About Glimsentro-M1 Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimsentro-M1 Tablet SR

Store this medication in its original, tightly closed container, as directed on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Glimsentro-M1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimsentro-M1 Tablet SR and seek immediate medical attention.
Glimsentro-M1 SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimsentro-M1 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glimsentro-M1 Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimsentro-M1 SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimsentro-M1 Tablet SR and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimsentro-M1 Tablet SR
89
MRP 109
18% off